137 related articles for article (PubMed ID: 12911542)
1. Classification and rescue of ROMK mutations underlying hyperprostaglandin E syndrome/antenatal Bartter syndrome.
Peters M; Ermert S; Jeck N; Derst C; Pechmann U; Weber S; Schlingmann KP; Seyberth HW; Waldegger S; Konrad M
Kidney Int; 2003 Sep; 64(3):923-32. PubMed ID: 12911542
[TBL] [Abstract][Full Text] [Related]
2. Functional heterogeneity of ROMK mutations linked to hyperprostaglandin E syndrome.
Jeck N; Derst C; Wischmeyer E; Ott H; Weber S; Rudin C; Seyberth HW; Daut J; Karschin A; Konrad M
Kidney Int; 2001 May; 59(5):1803-11. PubMed ID: 11318951
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the ROMK gene in antenatal Bartter syndrome are associated with impaired K+ channel function.
Derst C; Konrad M; Köckerling A; Károlyi L; Deschenes G; Daut J; Karschin A; Seyberth HW
Biochem Biophys Res Commun; 1997 Jan; 230(3):641-5. PubMed ID: 9015377
[TBL] [Abstract][Full Text] [Related]
4. Functional implications of mutations in the human renal outer medullary potassium channel (ROMK2) identified in Bartter syndrome.
Starremans PG; van der Kemp AW; Knoers NV; van den Heuvel LP; Bindels RJ
Pflugers Arch; 2002 Jan; 443(3):466-72. PubMed ID: 11810218
[TBL] [Abstract][Full Text] [Related]
5. Heterozygous mutations of the gene for Kir 1.1 (ROMK) in antenatal Bartter syndrome presenting with transient hyperkalemia, evolving to a benign course.
Cho JT; Guay-Woodford LM
J Korean Med Sci; 2003 Feb; 18(1):65-8. PubMed ID: 12589089
[TBL] [Abstract][Full Text] [Related]
6. Mutations in the gene encoding the inwardly-rectifying renal potassium channel, ROMK, cause the antenatal variant of Bartter syndrome: evidence for genetic heterogeneity. International Collaborative Study Group for Bartter-like Syndromes.
Hum Mol Genet; 1997 Jan; 6(1):17-26. PubMed ID: 9002665
[TBL] [Abstract][Full Text] [Related]
7. A hyperprostaglandin E syndrome mutation in Kir1.1 (renal outer medullary potassium) channels reveals a crucial residue for channel function in Kir1.3 channels.
Derst C; Wischmeyer E; Preisig-Müller R; Spauschus A; Konrad M; Hensen P; Jeck N; Seyberth HW; Daut J; Karschin A
J Biol Chem; 1998 Sep; 273(37):23884-91. PubMed ID: 9727001
[TBL] [Abstract][Full Text] [Related]
8. Functional consequences of ROMK mutants linked to antenatal Bartter's syndrome and implications for treatment.
Schwalbe RA; Bianchi L; Accili EA; Brown AM
Hum Mol Genet; 1998 Jun; 7(6):975-80. PubMed ID: 9580661
[TBL] [Abstract][Full Text] [Related]
9. Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K+ channel, ROMK.
Simon DB; Karet FE; Rodriguez-Soriano J; Hamdan JH; DiPietro A; Trachtman H; Sanjad SA; Lifton RP
Nat Genet; 1996 Oct; 14(2):152-6. PubMed ID: 8841184
[TBL] [Abstract][Full Text] [Related]
10. Endoplasmic reticulum-associated degradation of the renal potassium channel, ROMK, leads to type II Bartter syndrome.
O'Donnell BM; Mackie TD; Subramanya AR; Brodsky JL
J Biol Chem; 2017 Aug; 292(31):12813-12827. PubMed ID: 28630040
[TBL] [Abstract][Full Text] [Related]
11. A mutation linked with Bartter's syndrome locks Kir 1.1a (ROMK1) channels in a closed state.
Flagg TP; Tate M; Merot J; Welling PA
J Gen Physiol; 1999 Nov; 114(5):685-700. PubMed ID: 10532965
[TBL] [Abstract][Full Text] [Related]
12. Two novel mutations of the gene for Kir 1.1 (ROMK) in neonatal Bartter syndrome.
Vollmer M; Koehrer M; Topaloglu R; Strahm B; Omran H; Hildebrandt F
Pediatr Nephrol; 1998 Jan; 12(1):69-71. PubMed ID: 9502574
[TBL] [Abstract][Full Text] [Related]
13. Transient neonatal hyperkalemia in the antenatal (ROMK defective) Bartter syndrome.
Finer G; Shalev H; Birk OS; Galron D; Jeck N; Sinai-Treiman L; Landau D
J Pediatr; 2003 Mar; 142(3):318-23. PubMed ID: 12640382
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome.
Konrad M; Vollmer M; Lemmink HH; VAN DEN Heuvel LPWJ; Jeck N; Vargas-Poussou R; Lakings A; Ruf R; Deschênes G; Antignac C; Guay-Woodford L; Knoers NVAM; Seyberth HW; Feldmann D; Hildebrandt F
J Am Soc Nephrol; 2000 Aug; 11(8):1449-1459. PubMed ID: 10906158
[TBL] [Abstract][Full Text] [Related]
15. Mouse model of type II Bartter's syndrome. I. Upregulation of thiazide-sensitive Na-Cl cotransport activity.
Cantone A; Yang X; Yan Q; Giebisch G; Hebert SC; Wang T
Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1366-72. PubMed ID: 18385266
[TBL] [Abstract][Full Text] [Related]
16. Absence of small conductance K+ channel (SK) activity in apical membranes of thick ascending limb and cortical collecting duct in ROMK (Bartter's) knockout mice.
Lu M; Wang T; Yan Q; Yang X; Dong K; Knepper MA; Wang W; Giebisch G; Shull GE; Hebert SC
J Biol Chem; 2002 Oct; 277(40):37881-7. PubMed ID: 12130653
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanism of a COOH-terminal gating determinant in the ROMK channel revealed by a Bartter's disease mutation.
Flagg TP; Yoo D; Sciortino CM; Tate M; Romero MF; Welling PA
J Physiol; 2002 Oct; 544(2):351-62. PubMed ID: 12381810
[TBL] [Abstract][Full Text] [Related]
18. Genome mining yields new disease-associated ROMK variants with distinct defects.
Nguyen NH; Sarangi S; McChesney EM; Sheng S; Porter AW; Kleyman TR; Pitluk ZW; Brodsky JL
bioRxiv; 2023 May; ():. PubMed ID: 37214976
[TBL] [Abstract][Full Text] [Related]
19. [Bartter's syndrome].
Daniluk U; Kaczmarski M; Wasilewska J; Matuszewska E; Semeniuk J; Sidor K; Krasnow A
Pol Merkur Lekarski; 2004 May; 16(95):484-9. PubMed ID: 15518434
[TBL] [Abstract][Full Text] [Related]
20. Evidence for endocytosis of ROMK potassium channel via clathrin-coated vesicles.
Zeng WZ; Babich V; Ortega B; Quigley R; White SJ; Welling PA; Huang CL
Am J Physiol Renal Physiol; 2002 Oct; 283(4):F630-9. PubMed ID: 12217853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
